The targeting of cyclophilin D by RNAi as a novel cardioprotective therapy: evidence from two-photon imaging
Author(s) -
Masashi Kato,
Masaharu Akao,
Madoka Matsumoto-Ida,
Takeru Makiyama,
Moritake Iguchi,
Toshihiro Takeda,
Shigeomi Shimizu,
Toru Kita
Publication year - 2009
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvp094
Subject(s) - mitochondrial permeability transition pore , mptp , small interfering rna , gene silencing , microbiology and biotechnology , rna interference , reperfusion injury , mitochondrion , pharmacology , ischemia , biology , chemistry , medicine , cancer research , pathology , programmed cell death , transfection , biochemistry , cardiology , rna , apoptosis , disease , parkinson's disease , gene
An opening of the mitochondrial permeability transition pore (MPTP), which leads to the loss of mitochondrial membrane potential (DeltaPsi(m)), is the earliest event that commits cells to death, and this process is potentially a prime target for therapeutic intervention against myocardial ischaemia/reperfusion. We aimed to investigate the protective effects of RNA interference (RNAi)-mediated gene silencing of cyclophilin D (CypD), one of the putative components of the MPTP, against myocardial ischaemia/reperfusion using two-photon laser scanning microscopy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom